Federal Register / Vol. 83, No. 8 / Thursday, January 11, 2018 / Notices 1377 

Contact Person: Chee Lim, Ph.D., Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 4128, Bethesda, MD 20892, 301– 

435–1850, limc4@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Academic 

Research Enhancement Award. 

Date: February 16, 2018. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

Contact Person: Inna Gorshkova, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, 301–435–1784, gorshkoi@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 8, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–00388 Filed 1–10–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant and/or contract 

proposals applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

and/or contract proposals applications, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel TEP–9B: 

Cancer Cachexia Therapy. 

Date: February 6, 2018. 

Time: 10:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W030, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Jun Fang, Ph.D., Scientific 

Review Officer, Research Technology and 

Contract Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W246, Bethesda, MD 20892–9750, 

240–276–5460, jfang@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Development of Informatics Technologies for 

Cancer Research and Management. 

Date: February 8–9, 2018. 

Time: 5:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Cambria Hotel & Suites Rockville, 1 

Helen Henghan Way, Rockville, MD 20892. 

Contact Person: Saejeong J. Kim, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W640, Bethesda, MD 

20892–9750, 240–276–5179, saejeong.kim@

nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Program Project V (P01) Review. 

Date: February 14–15, 2018. 

Time: 5:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, MD 20878. 

Contact Person: Wlodek Lopaczynski, MD, 

Ph.D., Scientific Review Officer, Office of the 

Director, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W514, Bethesda, MD 

20892–9750, 240–276–6340, lopacw@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Innovative 

Molecular Analysis Technologies (IMAT). 

Date: February 15, 2018. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W030, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Yasuko Furumoto, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W424, Bethesda, MD 20892– 

9750, 240–276–5287, yasuko.furumoto@

nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Pancreatic 

Cancer Detection Consortium (U01). 

Date: February 15, 2018. 

Time: 11:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W240, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Hasan Siddiqui, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH 9609, Medical 

Center Drive, Room 7W240, Bethesda, MD 

20892–9750, 240–276–5122, hasan.siddiqui@

nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–5A: 

NCI Clinical and Translational Exploratory/ 

Developmental Studies. 

Date: February 15, 2018. 

Time: 11:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W238, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Byeong-Chel Lee, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W238, Bethesda, MD 20892–9750, 

240–276–7755, byeong-chel.lee@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; UH2 

Review. 

Date: February 27, 2018. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W608, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Robert E. Bird, Ph.D., 

Scientific Review Officer, Research Program 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W608, 

Bethesda, MD 20892–9750, 240–276–6344, 

birdr@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; R25 

Review. 

Date: February 28, 2018. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W608, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Robert E. Bird, Ph.D., 

Scientific Review Officer, Research Program 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W608, 

Bethesda, MD 20892–9750, 240–276–6344, 

birdr@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; R01 MultiSite. 

Date: March 6, 2018. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W608, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Robert E. Bird, Ph.D., 

Scientific Review Officer, Research Program 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W608, 

Bethesda, MD 20892–9750, 240–276–6344, 

birdr@mail.nih.gov. 


srobinson on DSK9F5VC42PROD with NOTICES
1378 Federal Register / Vol. 83, No. 8 / Thursday, January 11, 2018 / Notices 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Outstanding Investigator Award (OIA) II. 

Date: March 8–9, 2018. 

Time: 8:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, MD 20878. 

Contact Person: Caron A. Lyman, Ph.D., 

Scientific Review Officer, Research Program 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W126, 

Bethesda, MD 20892–9750, 240–276–6348, 

lymanc@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–9— 

Drug Development. 

Date: March 9, 2018. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W114, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Jeffrey E. DeClue, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W114, Bethesda, MD 20892– 

9750, 240–276–6371, decluej@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–1: 

Development of Software Tools for Post 

Radiation Therapy Surveillance. 

Date: March 13–14, 2018. 

Time: 4:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

North Bethesda, MD 20852. 

Contact Person: Shakeel Ahmad, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W102, Bethesda, MD 20892– 

9750, 240–276–6349, ahmads@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Emerging 

Questions in Cancer Systems Biology (U01). 

Date: March 16, 2018. 

Time: 8:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

2E908, Rockville, MD 20850. 

Contact Person: Timothy C. Meeker, MD, 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W606, Bethesda, MD 20892–9750, 

240–276–6464, meekert@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: January 5, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–00297 Filed 1–10–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Center for Substance Abuse 

Prevention; Notice of Meeting 

Pursuant to Public Law 92–463, 

notice is hereby given for the meeting of 

the Substance Abuse and Mental Health 

Services Administration’s (SAMHSA) 

Center for Substance Abuse Prevention 

National Advisory Council (CSAP NAC) 

on February 14, 2018. 

The Council was established to advise 

the Secretary, Department of Health and 

Human Services (HHS); the Assistant 

Secretary for Mental Health and 

Substance Use, SAMHSA; and Director, 

CSAP concerning matters relating to the 

activities carried out by and through the 

Center and the policies respecting such 

activities. 

The meeting will be open to the 

public and will include the discussion 

of the substance use prevention 

workforce and opioid use prevention. 

The meeting will also include updates 

on CSAP program developments. 

The meeting will be held in Rockville, 

Maryland. Attendance by the public 

will be limited to the space available. 

Interested persons may present data, 

information, or views, orally or in 

writing, on issues pending before the 

Council. Written submissions should be 

forwarded to the contact person on or 

before one week prior to the meeting. 

Oral presentations from the public will 

be scheduled at the conclusion of the 

meeting. Individuals interested in 

making oral presentations should notify 

the contact on or before one week prior 

to the meeting. Five minutes maximum 

will be allotted for each presentation. 

To attend onsite, submit written or 

brief oral comments, or request special 

accommodations for persons with 

disabilities, please register at the 

SAMHSA Committees’ website, http://

nac.samhsa.gov/Registration/ 

meetingsRegistration.aspx, or 

communicate with the CSAP Council’s 

Designated Federal Officer (see contact 

information below). 

Substantive program information may 

be obtained after the meeting by 

accessing the SAMHSA Committee 

website, http://nac.samhsa.gov/, or by 

contacting the Designated Federal 

Officer. 

Committee Name: Substance Abuse and 

Mental Health Services Administration, 

Center for Substance Abuse Prevention 

National Advisory Council. 

Date/Time/Type: February 14, 2018, from 

9:30 a.m. to 4:30 p.m. EST: (OPEN). 

Place: SAMHSA, 5600 Fishers Lane, Room 

5A02, Rockville, MD 20852, Adobe Connect 

webcast: https://samhsacsap.adobeconnect.com/nac/. 

Contact: Matthew J. Aumen, Designated 

Federal Officer, SAMHSA CSAP NAC, 5600 

Fishers Lane, Rockville, MD 20852, 

Telephone: 240–276–2440, Fax: 301–480– 

8480, Email: matthew.aumen@

samhsa.hhs.gov. 

Carlos Castillo, 

Committee Management Officer, SAMHSA. 

[FR Doc. 2018–00369 Filed 1–10–18; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF THE INTERIOR 

Fish and Wildlife Service 

[Docket No. FWS–HQ–IA–2017–0086; 

FXIA16710900000–178–FF09A30000] 

Foreign Endangered and Threatened 

Species; Receipt of Permit 

Applications 

AGENCY: Fish and Wildlife Service, 

Interior. 

ACTION: Notice of receipt of permit 

applications. 

SUMMARY: We, the U.S. Fish and 

Wildlife Service, invite the public to 

comment on applications to conduct 

certain activities with foreign 

endangered and threatened species. 

With some exceptions, the Endangered 

Species Act prohibits activities with 

listed species unless Federal 

authorization is acquired that allows 

such activities. The ESA also requires 

that we invite public comment before 

issuing these permits. 

DATES: We must receive comments by 

February 12, 2018. 

ADDRESSES:

Document availability: The 

applications, as well as any comments 

and other materials that we receive, will 

be available for public inspection online 

in Docket No. FWS–HQ–IA–2017–0086 

at http://www.regulations.gov. 

Submitting comments: You may 

submit comments by one of the 

following methods: 


srobinson on DSK9F5VC42PROD with NOTICES